Yan'e Liu

Identification of RPGRIP1L as an instability-maintaining gene to drive tumor growth and PD-L1 expression via Hedgehog signaling in breast cancer.

Journal: BMC cancer

Published: September 30, 2025

Prognostic implications of antitumour efficacy and adverse events of EGFR-TKIs in non-small cell lung cancer: an ambispective cohort study.

Journal: European journal of pharmacology

Published: April 22, 2025

Recurrent Checkpoint Inhibitor-Related Pneumonitis Refractory to Corticosteroid Treatment: A Case Report and Literature Review.

Journal: Clinical pharmacology : advances and applications

Published: April 19, 2025

Real-world prognostic factors for first-line EGFR-TKI efficacy in advanced NSCLC patients harboring EGFR 21 L858R mutation.

Journal: Global medical genetics

Published: February 09, 2025

Progression-Free Survival Prediction Model Based on AI-Enhanced Dynamic Radiomics for Personalized EGFR-TKI Treatment Monitoring Patients With Lung Adenocarcinoma.

Journal: Thoracic cancer

Published: December 25, 2024

Modeling exposure-driven adverse events of EGFR TKIs in the treatment of patients with non-small cell lung cancer.

Journal: Acta pharmacologica Sinica

Published: December 13, 2024

Changes in Intestinal Flora and Serum Metabolites Pre- and Post-Antitumor Drug Therapy in Patients with Non-Small Cell Lung Cancer.

Journal: Journal of clinical medicine

Published: December 05, 2023

SN-38, an active metabolite of irinotecan, inhibits transcription of nuclear factor erythroid 2-related factor 2 and enhances drug sensitivity of colorectal cancer cells.

Journal: Molecular carcinogenesis

Published: October 15, 2023

Clinical Characteristics and Prognosis of 76 Lung Adenocarcinoma Patients  Harboring EGFR Mutations with Pleural Effusion at Initial Diagnosis:  A Single-center Retrospective Study

Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer

Published: March 27, 2022

Characteristics and Clinical Implication of UGT1A1 Heterozygous Mutation in Tumor.

Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer

Published: March 27, 2022

Dilemma and solutions of treatment delay in cancer patients during the COVID-19 pandemic: A single-center, prospective survey.

Journal: Asia-Pacific journal of clinical oncology

Published: July 29, 2021

A Novel Circular RNA circPTCD3 Promotes Breast Cancer Progression Through Sponging miR-198.

Journal: Cancer management and research

Published: March 30, 2020

Identification of RPGRIP1L as an instability-maintaining gene to drive tumor growth and PD-L1 expression via Hedgehog signaling in breast cancer.

Identification of RPGRIP1L as an instability-maintaining gene to drive tumor growth and PD-L1 expression via Hedgehog signaling in breast cancer.

Prognostic implications of antitumour efficacy and adverse events of EGFR-TKIs in non-small cell lung cancer: an ambispective cohort study.

Prognostic implications of antitumour efficacy and adverse events of EGFR-TKIs in non-small cell lung cancer: an ambispective cohort study.

Recurrent Checkpoint Inhibitor-Related Pneumonitis Refractory to Corticosteroid Treatment: A Case Report and Literature Review.

Recurrent Checkpoint Inhibitor-Related Pneumonitis Refractory to Corticosteroid Treatment: A Case Report and Literature Review.

Real-world prognostic factors for first-line EGFR-TKI efficacy in advanced NSCLC patients harboring EGFR 21 L858R mutation.

Real-world prognostic factors for first-line EGFR-TKI efficacy in advanced NSCLC patients harboring EGFR 21 L858R mutation.

Progression-Free Survival Prediction Model Based on AI-Enhanced Dynamic Radiomics for Personalized EGFR-TKI Treatment Monitoring Patients With Lung Adenocarcinoma.

Progression-Free Survival Prediction Model Based on AI-Enhanced Dynamic Radiomics for Personalized EGFR-TKI Treatment Monitoring Patients With Lung Adenocarcinoma.

Modeling exposure-driven adverse events of EGFR TKIs in the treatment of patients with non-small cell lung cancer.

Modeling exposure-driven adverse events of EGFR TKIs in the treatment of patients with non-small cell lung cancer.

Changes in Intestinal Flora and Serum Metabolites Pre- and Post-Antitumor Drug Therapy in Patients with Non-Small Cell Lung Cancer.

Changes in Intestinal Flora and Serum Metabolites Pre- and Post-Antitumor Drug Therapy in Patients with Non-Small Cell Lung Cancer.

SN-38, an active metabolite of irinotecan, inhibits transcription of nuclear factor erythroid 2-related factor 2 and enhances drug sensitivity of colorectal cancer cells.

SN-38, an active metabolite of irinotecan, inhibits transcription of nuclear factor erythroid 2-related factor 2 and enhances drug sensitivity of colorectal cancer cells.

Clinical Characteristics and Prognosis of 76 Lung Adenocarcinoma Patients Harboring EGFR Mutations with Pleural Effusion at Initial Diagnosis: A Single-center Retrospective Study

Clinical Characteristics and Prognosis of 76 Lung Adenocarcinoma Patients Harboring EGFR Mutations with Pleural Effusion at Initial Diagnosis: A Single-center Retrospective Study

Characteristics and Clinical Implication of UGT1A1 Heterozygous Mutation in Tumor.

Characteristics and Clinical Implication of UGT1A1 Heterozygous Mutation in Tumor.

Dilemma and solutions of treatment delay in cancer patients during the COVID-19 pandemic: A single-center, prospective survey.

Dilemma and solutions of treatment delay in cancer patients during the COVID-19 pandemic: A single-center, prospective survey.

A Novel Circular RNA circPTCD3 Promotes Breast Cancer Progression Through Sponging miR-198.

A Novel Circular RNA circPTCD3 Promotes Breast Cancer Progression Through Sponging miR-198.

Clinical Characteristics and Prognosis of 76 Lung Adenocarcinoma Patients  Harboring EGFR Mutations with Pleural Effusion at Initial Diagnosis:  A Single-center Retrospective Study

Clinical Characteristics and Prognosis of 76 Lung Adenocarcinoma Patients  Harboring EGFR Mutations with Pleural Effusion at Initial Diagnosis:  A Single-center Retrospective Study